Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Angiogenesis Related Compound Library: Research Guide

Angiogenesis Related compound Library is a curated collection of bioactive small molecules targeting key regulators of angiogenesis, designed to accelerate high-throughput screening and mechanistic research in vascular biology and oncology.

Selleck Reference Number
L5200
Primary Application
High-throughput screening, target validation, angiogenesis drug discovery
Key Research Areas
Oncology, vascular biology, wound healing, ophthalmic diseases
Compound Classes Covered
VEGF pathway inhibitors, RTK inhibitors, HIF modulators, and related bioactive molecules

Key Molecular Targets and Compound Classes

The Angiogenesis Related Compound Library encompasses compounds acting on a broad spectrum of validated angiogenic targets. Understanding these target classes helps researchers select the most relevant subsets for their experimental models.

VEGF/VEGFR Pathway: VEGF and its receptors (VEGFR1, VEGFR2, VEGFR3) represent the central axis of angiogenic signaling. Inhibitors of this pathway are among the most clinically validated anti-angiogenic agents. The library includes receptor tyrosine kinase (RTK) inhibitors and neutralizing tool compounds that disrupt VEGF-mediated endothelial cell proliferation, migration, and tube formation.

HIF Modulators: Hypoxia-inducible factors (HIF-1α, HIF-2α) are master transcriptional regulators of the angiogenic response under oxygen-deficient conditions. The library contains inhibitors of HIF prolyl hydroxylases and direct HIF pathway modulators relevant to hypoxia-driven tumor angiogenesis.

RTK and Kinase Inhibitors: Beyond VEGFR, the library covers inhibitors of PDGFR, FGFR, Tie2/TEK, and Eph receptors — all of which contribute to vessel stabilization, pericyte recruitment, and endothelial cell survival. PI3K, AKT, mTOR, MEK, and ERK inhibitors acting downstream of these receptors are also represented.

Matrix Remodeling and Integrin Modulators: Angiogenesis requires extracellular matrix remodeling mediated by matrix metalloproteinases (MMPs) and integrin-dependent cell adhesion. MMP inhibitors and integrin-targeting compounds within the library provide tools to study these processes.

Additional Bioactive Molecules: The collection also includes natural product derivatives, approved drugs with known anti-angiogenic activity, and tool compounds for studying Notch, Wnt, and Hedgehog pathways, which modulate vessel morphogenesis and specification.

Screening Applications and Experimental Utility

The Angiogenesis Related Compound Library is optimized for a range of in vitro and cell-based assay formats commonly used in angiogenesis research. Its breadth of mechanistic coverage and compound diversity make it particularly valuable for phenotypic and target-based screening campaigns.

High-Throughput and High-Content Screening (HTS/HCS): The library is formatted to support automated liquid-handling workflows. Researchers can deploy it in endothelial tube formation assays (e.g., Matrigel-based), endothelial cell proliferation assays, wound-healing/scratch assays, and spheroid sprouting assays to rapidly identify hits that modulate angiogenic phenotypes.

Target Validation and Pathway Dissection: Individual compounds or focused subsets can be used to confirm the functional contribution of specific molecular targets in primary human umbilical vein endothelial cells (HUVECs), co-culture models, or organotypic systems. Dose-response profiling of library hits enables SAR (structure-activity relationship) insight even at the screening stage.

Oncology and Tumor Microenvironment Studies: Because tumor vascularization is a recognized hallmark of cancer, the library supports anti-tumor angiogenesis research. Compounds can be tested in co-culture systems combining tumor cells and endothelial cells to assess effects on vessel co-option and neovascularization within the tumor microenvironment.

Ophthalmic Disease Models: The library is relevant for studying pathological ocular angiogenesis as modeled in retinal pigment epithelial (RPE) cell systems and choroidal sprouting assays relevant to conditions such as wet age-related macular degeneration (AMD) and proliferative diabetic retinopathy.

Combination and Synergy Studies: The library's scope allows researchers to design matrix combination experiments to identify synergistic or antagonistic interactions between compounds targeting different nodes of the angiogenic signaling network.

Ordering, Storage, and Quality Specifications

The Angiogenesis Related Compound Library is available from Aladdin Scientific under SKU Lib412056. Researchers and procurement teams should consider the following practical points when ordering and handling this compound collection.

Format and Delivery: Compound libraries are typically supplied as pre-dissolved DMSO stock solutions in plate format (e.g., 96-well or 384-well plates), enabling direct integration with automated screening platforms. Exact plate format, concentration, and volume per well should be confirmed at the time of ordering to match the laboratory's specific assay requirements.

Storage Conditions: DMSO-dissolved small molecule libraries should generally be stored at -20°C or -80°C, sealed and protected from moisture, to maintain compound integrity over time. Repeated freeze-thaw cycles should be minimized. Specific storage recommendations for the Angiogenesis Related Compound Library are provided in the accompanying product documentation.

Purity and Identity: Compounds within Aladdin Scientific's libraries are sourced from quality-controlled suppliers and are typically characterized by HPLC purity analysis and mass spectrometry confirmation. Certificate of Analysis (CoA) documentation is available to support GLP or institutional quality requirements.

Customization: Researchers requiring a focused sub-library — for example, a subset enriched in VEGFR inhibitors or HIF pathway modulators — should contact Aladdin Scientific's technical support team to discuss custom library configurations tailored to specific research programs.

Regulatory and Safety: As with all research reagents, compounds should be handled in accordance with the relevant Safety Data Sheets (SDS). These products are for research use only and are not intended for therapeutic, diagnostic, or veterinary use.

Frequently asked questions

What types of compounds are included in the Angiogenesis Related Compound Library?

The library includes bioactive small molecules targeting key angiogenic pathways, such as VEGFR inhibitors, PDGFR and FGFR inhibitors, HIF pathway modulators, PI3K/AKT/mTOR and MAPK/ERK inhibitors, MMP inhibitors, and integrin-targeting compounds. Approved drugs with known anti-angiogenic activity and natural product-derived tool compounds are also represented.

What assay formats are compatible with the Angiogenesis Related Compound Library?

The Angiogenesis Related Compound Library is compatible with a broad range of assay formats including endothelial tube formation assays, cell proliferation assays, scratch/wound-healing assays, spheroid sprouting assays, and high-throughput or high-content screening platforms. Its plate-based DMSO stock format supports direct integration with automated liquid-handling systems.

How should the Angiogenesis Related Compound Library be stored to preserve compound activity?

The library should be stored as DMSO stock solutions at -20°C or -80°C in sealed plates, protected from moisture and light. Repeated freeze-thaw cycles should be avoided to maintain compound integrity and potency. Refer to the product-specific CoA and SDS for detailed storage guidance.

Can the library be customized to focus on a specific angiogenesis target class?

Yes, Aladdin Scientific offers customization options for researchers requiring focused sub-libraries, such as subsets enriched in VEGFR inhibitors or HIF modulators. Researchers should contact Aladdin Scientific's technical support team with their specific requirements to discuss available configurations and pricing.

Is the Angiogenesis Related Compound Library suitable for oncology research?

Yes. Tumor angiogenesis is a well-established hallmark of cancer, and the Angiogenesis Related Compound Library is well-suited for oncology applications including anti-tumor angiogenesis screening, tumor microenvironment studies, and identification of compounds that inhibit tumor-associated neovascularization in co-culture or 3D tumor models.

References

  1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine. 1995.
  2. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011.
  3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Medicine. 2003.
  4. Semenza GL. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer. 2003.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Angiogenesis Related Compound Library: Research Guide" Aladdin Knowledge Base, updated 19 nov. 2026. https://www.aladdinsci.com/us_fr/faqs/angiogenesis-related-compound-library-research-guide-en.html
Was this article helpful? Yes No 8 out of 16 found this helpful

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.